Vysis, Inc., a leading genomic disease management company, was acquired the same year to strengthen Abbott's position in the molecular diagnostics market. The Vysis UroVysion molecular test to ...

Last month the World Health Organization approved the use of the first diagnostic test for mpox called the Alinity m MPXV ...

The Africa Centres for Disease Control and Prevention (Africa CDC) announced Thursday its endorsement of Morocco's locally ...

The African Centre for Disease Control (Africa CDC) has approved the first Polymerase Chain Reaction (PCR) test for Mpox in ...

Andrews Joins as CEO's Strategic Consultant to Accelerate Growth Initiatives BINYAMINA, Israel and CARY, N.C, Nov. 1 ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into ...

The latest Greg Abbott news from The Texas Tribune. By Kate McGee Updated: 8 hours ago The governor’s directive extends a tuition freeze for Texas’ public universities that was approved in the ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...